| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |